Two small studies have reported the presence of a hypomethylation pattern in ten [20] and fifteen [21] patients with post-COVID-19 condition, whereas our research group did not identify an association between the methylation levels of the ACE2 promoter and specific post-COVID symptoms, e.g., fatigue, concentration loss, or fatigue [22]. The gene discussed is ACE2; the disease is COVID-19.